{"url":"https://lda.senate.gov/api/v1/filings/463bdb4e-94f5-486f-a4c3-64cd7d2467f1/","filing_uuid":"463bdb4e-94f5-486f-a4c3-64cd7d2467f1","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2021,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/463bdb4e-94f5-486f-a4c3-64cd7d2467f1/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Nathan Groth","dt_posted":"2021-10-19T13:22:56.163000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1000 Maine Avenue SW","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":401103565,"url":"https://lda.senate.gov/api/v1/registrants/401103565/","house_registrant_id":null,"name":"MICHAEL BEST STRATEGIES LLC","description":"Government Relations Firm","address_1":"1000 Maine Avenue SW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TORY SENDEK","contact_telephone":"+1 202-844-3813","dt_updated":"2026-01-30T15:48:16.228646-05:00"},"client":{"id":209554,"url":"https://lda.senate.gov/api/v1/clients/209554/","client_id":874,"name":"AMNEAL PHARMACEUTICAL","general_description":"pharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-03-30"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"issues related to reshoring pharmaceutical supply chain","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65438,"prefix":null,"prefix_display":null,"first_name":"DENISE","nickname":null,"middle_name":null,"last_name":"BODE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":93440,"prefix":null,"prefix_display":null,"first_name":"LUCIA","nickname":null,"middle_name":null,"last_name":"ALONZO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":100915,"prefix":null,"prefix_display":null,"first_name":"ANDREA","nickname":null,"middle_name":null,"last_name":"RICCIO","suffix":null,"suffix_display":null},"covered_position":"Deputy Director Democratic Policy and Communications Committee, House of Representatives","new":false},{"lobbyist":{"id":73575,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"ANGELSON","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President, White House Legislative Affairs","new":false}],"government_entities":[{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}